AI assistant
DEXCOM INC — Director's Dealing 2023
May 22, 2023
30198_dirs_2023-05-22_5e8a2ff8-8c78-4437-8afa-0ebeff540d35.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2023-05-18
Reporting Person: KAHN BARBARA (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-18 | Common Stock | A | 2927 | $0.001 | Acquired | 6903 | Direct |
| 2023-05-18 | Common Stock | G | 3976 | $0.0 | Disposed | 2927 | Direct |
| 2023-05-18 | Common Stock | G | 3976 | $0.0 | Acquired | 19648 | Indirect |
Footnotes
F1: The RSU Award was granted on May 18, 2023 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2024 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.
F2: Shares were transferred from direct ownership to ownership under the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, upon vesting of previously awarded restricted stock units.
F3: Shares are held by the Barbara Kahn TTEE Barbara Kahn Rev TRT DTD 6/26/96 & Robert Meyer TTEE Robert Meyer Rev Trst DTD 6/26/96, with respect to which the reporting person is a trustee.